Triliance Polymers Q1 FY27 PAT at 5.18L vs 1.69L; no operating revenue

Pat Growth 25pctResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.4%Reaction day

₹44.05

prior close

₹46.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+4.3% vs market

Diversified Commercial Services peers, median of 72sector-0.7%+5.1% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 5.1 pts more than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.4+0.1+4.3-0.7+5.1

Next day

-3.3+0.2-3.5-1.0-2.3

+1.0+0.6+0.4-1.0+2.0

—-0.0—-1.6—

+1.0+0.5+0.5-1.6+2.6

+1.0+0.8+0.3-1.4+2.4

+1.0+0.6+0.4-1.0+2.0

15d

+4.4+1.3+3.2-1.9+6.3

—-1.4—-3.6—

+4.3-0.6+4.8-5.0+9.3

—————

UpDownMarket · Nifty Microcap 250Sector · Diversified Commercial Services peers, median of 72Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Triliance Polymers (formerly Leena Consultancy) reported Q1 FY26-27 results with no revenue from operations, only other income of 13.39 lakh, flat year on year. Total expenses fell to 6.47 lakh from 11.11 lakh. PAT rose sharply to 5.18 lakh from 1.69 lakh in Q1 FY25, a jump of about 206 percent, though from a very small base. EPS stood at 0.11. Auditor Motilal and Associates issued a clean limited review report with no qualifications.

Likely market impact

Big PAT growth from a tiny base is encouraging, but the company has no operating revenue, so core business health remains unclear.